Chalmers James D, Timothy Alan, Polverino Eva, Almagro Marta, Ruddy Thomas, Powell Pippa, Boyd Jeanette
Scottish Centre for Respiratory Research, University of Dundee, Ninewells Hospital and Medical School, Dundee, UK.
EMBARC/ELF bronchiectasis patient advisory group.
Breathe (Sheff). 2017 Sep;13(3):194-207. doi: 10.1183/20734735.009517.
The European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC) is a European Respiratory Society (ERS) Clinical Research Collaboration dedicated to improving research and clinical care for people with bronchiectasis. EMBARC has created a European Bronchiectasis Registry, funded by the ERS and by the European Union (EU) Innovative Medicines Initiative Programme. From the outset, EMBARC had the ambition to be a patient-focussed project. In contrast to many respiratory diseases, however, there are no specific patient charities or European patient organisations for patients with bronchiectasis and no existing infrastructure for patient engagement. This article describes the experience of EMBARC and the European Lung Foundation in establishing a patient advisory group and then engaging this group in European guidelines, an international registry and a series of research studies. Patient involvement in research, clinical guidelines and educational activities is increasingly advocated and increasingly important. Genuine patient engagement can achieve a number of goals that are critical to the success of an EU project, including focussing activities on patient priorities, allowing patients to direct the clinical and research agenda, and dissemination of guidelines and research findings to patients and the general public. Here, we review lessons learned and provide guidance for future ERS task forces, EU-funded projects or clinical research collaborations that are considering patient involvement.
To understand the different ways in which patients can contribute to clinical guidelines, research projects and educational activities.To understand the barriers and potential solutions to these barriers from a physician's perspective, in order to ensure meaningful patient involvement in clinical projects.To understand the barriers and potential solutions from a patient's perspective, in order to meaningfully involve patients in clinical projects.
欧洲多中心支气管扩张症审计与研究协作组织(EMBARC)是欧洲呼吸学会(ERS)的临床研究协作组织,致力于改善支气管扩张症患者的研究和临床护理。EMBARC创建了欧洲支气管扩张症登记处,由ERS和欧盟创新药物倡议计划资助。从一开始,EMBARC就立志成为一个以患者为中心的项目。然而,与许多呼吸系统疾病不同的是,目前没有专门针对支气管扩张症患者的慈善机构或欧洲患者组织,也没有现有的患者参与基础设施。本文描述了EMBARC和欧洲肺部基金会在建立患者咨询小组并让该小组参与欧洲指南制定、国际登记处工作以及一系列研究的经验。患者参与研究、临床指南制定和教育活动的倡导力度越来越大,也越来越重要。真正的患者参与能够实现一些对欧盟项目成功至关重要的目标,包括将活动重点放在患者优先事项上、让患者主导临床和研究议程,以及向患者和公众传播指南和研究结果。在此,我们回顾经验教训,并为未来考虑患者参与的ERS工作组、欧盟资助项目或临床研究协作提供指导。
了解患者为临床指南、研究项目和教育活动做出贡献的不同方式。从医生的角度理解这些障碍以及针对这些障碍的潜在解决方案,以确保患者有意义地参与临床项目。从患者的角度理解障碍和潜在解决方案,以便让患者有意义地参与临床项目。